Millennium Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Sell |
996,826
-120,616
| -11% | -$450K | ﹤0.01% | 2269 |
|
|
2025
Q1 | $3.08M | Sell |
1,117,442
-492,773
| -31% | -$1.36M | ﹤0.01% | 2298 |
|
|
2024
Q4 | $8.92M | Buy |
1,610,215
+31,681
| +2% | +$176K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $13.2M | Buy |
1,578,534
+438,142
| +38% | +$3.65M | 0.01% | 1373 |
|
|
2024
Q2 | $7.77M | Sell |
1,140,392
-2,292,400
| -67% | -$15.6M | ﹤0.01% | 1636 |
|
|
2024
Q1 | $22.5M | Buy |
3,432,792
+1,444,151
| +73% | +$9.47M | 0.01% | 992 |
|
|
2023
Q4 | $12.9M | Buy |
1,988,641
+374,080
| +23% | +$2.43M | 0.01% | 1304 |
|
|
2023
Q3 | $8.12M | Sell |
1,614,561
-667,681
| -29% | -$3.36M | ﹤0.01% | 1566 |
|
|
2023
Q2 | $20M | Buy |
2,282,242
+1,199,859
| +111% | +$10.5M | 0.01% | 986 |
|
|
2023
Q1 | $12.8M | Sell |
1,082,383
-374,822
| -26% | -$4.44M | 0.01% | 1246 |
|
|
2022
Q4 | $14.8M | Buy |
1,457,205
+1,074,492
| +281% | +$10.9M | 0.01% | 1229 |
|
|
2022
Q3 | $2.25M | Buy |
382,713
+105,025
| +38% | +$619K | ﹤0.01% | 2773 |
|
|
2022
Q2 | $689K | Buy |
277,688
+189,178
| +214% | +$469K | ﹤0.01% | 3684 |
|
|
2022
Q1 | $263K | Buy |
88,510
+35,229
| +66% | +$105K | ﹤0.01% | 4521 |
|
|
2021
Q4 | $377K | Buy |
+53,281
| New | +$377K | ﹤0.01% | 4209 |
|
|
2021
Q3 | – | Sell |
-14,769
| Closed | -$181K | – | 5465 |
|
|
2021
Q2 | $181K | Buy |
+14,769
| New | +$181K | ﹤0.01% | 4733 |
|